Cathie Wood ARK Investment Management
Cathie Wood is the founder, CEO, and CIO of ARK Investment Management, an investment firm known for its focus on “disruptive innovation”. She gained widespread attention for her bold market calls and high conviction in cutting-edge technologies such as electric vehicles, genomics, and blockchain. Under her guidance, ARK’s exchange-traded funds (ETFs) attracted substantial interest from both retail and institutional investors. Wood’s investment philosophy emphasizes research-driven analysis and long-term growth potential, positioning her as one of today’s most influential voices in the world of finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coinbase
COIN
|
+$155M |
| 2 |
Tesla
TSLA
|
+$142M |
| 3 |
XYZ
Block Inc
XYZ
|
+$110M |
| 4 |
Teladoc Health
TDOC
|
+$44.3M |
| 5 |
Unity
U
|
+$42.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXAS
Exact Sciences
EXAS
|
+$300M |
| 2 |
Twilio
TWLO
|
+$71.5M |
| 3 |
Fate Therapeutics
FATE
|
+$42.5M |
| 4 |
monday.com
MNDY
|
+$31.1M |
| 5 |
NVIDIA
NVDA
|
+$23.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.93% |
| 2 | Healthcare | 30.64% |
| 3 | Consumer Discretionary | 12.06% |
| 4 | Communication Services | 9.71% |
| 5 | Financials | 7.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Tesla
TSLA
$1.43T
| $1.13B | 7.76% |
5,439,635
+814,163
| +18% | +$142M |
|
2
Roku
ROKU
$23.4B
| $822M | 5.65% |
12,483,431
+368,450
| +3% | +$21.6M |
|
3
Zoom
ZM
$31.5B
| $802M | 5.51% |
10,867,033
+251,142
| +2% | +$18.1M |
|
|
4
Coinbase
COIN
$49.2B
| $796M | 5.47% |
11,776,015
+2,586,742
| +28% | +$155M |
|
5
UiPath
PATH
$8.49B
| $788M | 5.42% |
44,891,966
+837,124
| +2% | +$12.6M |
|
|
EXAS
6
DELISTED
Exact Sciences
EXAS
| $772M | 5.3% |
11,379,187
-4,661,303
| -29% | -$300M |
|
|
XYZ
7
Block Inc
XYZ
$49.4B
| $719M | 4.94% |
10,470,931
+1,467,630
| +16% | +$110M |
|
8
Shopify
SHOP
$192B
| $670M | 4.61% |
13,985,791
+706,688
| +5% | +$31.1M |
|
|
9
Teladoc Health
TDOC
$1.16B
| $533M | 3.66% |
20,584,180
+1,655,740
| +9% | +$44.3M |
|
10
DraftKings
DKNG
$13B
| $463M | 3.18% |
23,931,255
-1,100,829
| -4% | -$18.3M |
|
|
11
Twilio
TWLO
$34.6B
| $416M | 2.86% |
6,250,001
-1,159,944
| -16% | -$71.5M |
|
12
Roblox
RBLX
$27.4B
| $406M | 2.79% |
9,026,480
+561,670
| +7% | +$21.5M |
|
|
13
Unity
U
$20.7B
| $399M | 2.74% |
12,307,660
+1,335,347
| +12% | +$42.9M |
|
14
Intellia Therapeutics
NTLA
$1.8B
| $367M | 2.52% |
9,837,166
+416,384
| +4% | +$16.3M |
|
15
CRISPR Therapeutics
CRSP
$5.75B
| $361M | 2.48% |
7,990,188
+160,256
| +2% | +$7.78M |
|
16
PagerDuty
PD
$950M
| $344M | 2.36% |
9,830,009
-267,235
| -3% | -$7.85M |
|
17
Pacific Biosciences
PACB
$420M
| $321M | 2.21% |
27,753,679
+2,061,998
| +8% | +$20.5M |
|
18
Robinhood
HOOD
$97.2B
| $308M | 2.12% |
31,734,313
+2,488,889
| +9% | +$23.7M |
|
19
Beam Therapeutics
BEAM
$3.07B
| $263M | 1.8% |
8,573,429
+360,298
| +4% | +$14.2M |
|
20
10x Genomics
TXG
$8.48B
| $232M | 1.59% |
4,155,323
-161,244
| -4% | -$7.53M |
|
21
Ginkgo Bioworks
DNA
$498M
| $219M | 1.51% |
4,118,925
+509,323
| +14% | +$32.3M |
|
22
Veracyte
VCYT
$3.4B
| $188M | 1.29% |
8,409,106
+108,865
| +1% | +$2.63M |
|
|
23
NVIDIA
NVDA
$5.2T
| $115M | 0.79% |
4,143,190
-1,088,620
| -21% | -$23.6M |
|
24
Twist Bioscience
TWST
$9.13B
| $108M | 0.74% |
7,179,112
+478,257
| +7% | +$10.6M |
|
25
Schrodinger
SDGR
$1.47B
| $103M | 0.71% |
3,906,709
+54,672
| +1% | +$1.3M |
|
Similar funds
Cathie Wood's Q1 2023 Portfolio in Review
As of Q1 2023, Cathie Wood held 238 positions worth $14.6B, up 26% from $11.5B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Cathie Wood's Q1 2023 filing shows 6 new, 81 increased, 131 reduced and 17 closed positions. Its largest new stake was Advanced Micro Devices: 186,677 shares worth $18.3M. The largest sale was Exact Sciences, an estimated $300M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Cathie Wood's largest Q1 2023 buy was Advanced Micro Devices: 186,677 shares worth $18.3M.
- Cathie Wood added most to Coinbase in Q1 2023, an estimated $155M increase.
- Cathie Wood's biggest Q1 2023 reduction was Exact Sciences, cutting an estimated $300M.
- Cathie Wood fully exited Fate Therapeutics in Q1 2023, selling an estimated $42.5M.
- Cathie Wood's ten largest holdings make up 52% of its $14.6B portfolio in Q1 2023.
- Cathie Wood opened 6 new positions and closed 17 in Q1 2023.
- Cathie Wood's portfolio value rose 26% quarter-over-quarter to $14.6B.
Based on ARK Investment Management's 13F filing for Q1 2023, filed 17 Apr 2023.